Fuelcell Energy, Inc. (NASDAQ: FCEL): this fuel-cell power plant company narrowed its losses and beat revenue expectations. Shares rose to $11.85 against a 52-week low of $5.84.
Perrigo Company (NASDAQ: PRGO): The FDA cleared the company's over-the-counter heartburn drug. Shares traded up to a high of $34.19 compared to a 52-week low of $16.09.
McDonald's Corporation (NYSE: MCD): Strong same-store sales carried over to a second day of buying in the shares. Stock moved to a peak of $63.49 against a 52-week low of $42.31.
Incyte Corporation (NASDAQ: INCY): Early trials of new drug are promising. Shares moved up to $10.29 compared to 52-week low of $4.75.
Douglas A. McIntyre is an editor at 247wallst.com.


Reveo is a technology incubator which has proven that they are worth keeping an eye on. At least indirectly, Reveo competes with companies such as IBM (NYSE: IBM) and 3M (NYSE: MMM). To date Reveo holds over 300 patents in the fields of electrochemistry, optics, fuel cells, and advanced materials. This is the kind of company that invents and develops the technologies of which your future shall be built upon.
General Electric Company (NYSE: GE) ended the day at $36.22, up 5 cents or 0.14%, holding onto its general upward trend this week, and over the last three months where it has gained some 10%. Not bad at all for a slow moving giant conglomerate. Today GE also announced that is has developed a protoype of a 

